Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 40.59%4.6B | 4.72%1.7B | -2.93%741.52M | 15.80%4.3B | 22.84%3.27B | 15.33%1.62B | 24.60%763.92M | -8.63%3.71B | 3.41%2.66B | 2.73%1.41B |
| Refunds of taxes and levies | 238.91%84.04M | -88.71%2.14M | 69.28%169.9K | 280.54%86.89M | 162.85%24.8M | 117.14%18.92M | 197.39%100.37K | -88.38%22.83M | -95.09%9.43M | -93.88%8.71M |
| Cash received relating to other operating activities | -17.97%58.01M | -21.56%40.63M | -21.57%20.17M | 112.77%112.88M | 89.46%70.71M | 105.96%51.8M | -1.69%25.71M | -25.58%53.05M | -77.14%37.32M | -57.24%25.15M |
| Cash inflows from operating activities | 40.82%4.74B | 2.87%1.74B | -3.53%761.86M | 18.75%4.5B | 24.25%3.36B | 17.53%1.69B | 23.53%789.73M | -12.53%3.79B | -7.53%2.71B | -8.28%1.44B |
| Goods services cash paid | -9.43%284.73M | -16.90%200.21M | 37.55%67.11M | 30.40%463.16M | 5.75%314.38M | 64.85%240.92M | 1.04%48.79M | 0.35%355.18M | 39.06%297.3M | -22.67%146.14M |
| Staff behalf paid | 9.48%223.62M | 11.78%150.02M | 10.70%83.86M | 21.24%370.73M | 16.61%204.26M | 18.74%134.21M | 11.68%75.75M | 9.17%305.79M | 11.18%175.17M | 6.01%113.03M |
| All taxes paid | -12.17%428.97M | -11.08%235.81M | -12.68%87.04M | 15.50%629.23M | 21.07%488.41M | 16.39%265.2M | -5.52%99.68M | -13.40%544.8M | -20.48%403.41M | -11.26%227.86M |
| Cash paid relating to other operating activities | -16.41%131.29M | -39.76%79.45M | -55.65%69.03M | 72.75%212.09M | 47.63%157.07M | 114.57%131.89M | 268.25%155.64M | -22.04%122.78M | -57.54%106.39M | -30.85%61.47M |
| Cash outflows from operating activities | -8.20%1.07B | -13.82%665.5M | -19.17%307.03M | 26.09%1.68B | 18.51%1.16B | 40.79%772.22M | 43.95%379.87M | -6.48%1.33B | -13.02%982.26M | -14.47%548.5M |
| Net cash flows from operating activities | 66.76%3.67B | 16.89%1.07B | 10.97%454.83M | 14.79%2.82B | 27.51%2.2B | 3.21%919.41M | 9.18%409.87M | -15.48%2.46B | -4.09%1.73B | -4.01%890.83M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -92.18%30.35M | -94.53%21.23M | ---- |
| Cash received from returns on investments | 97.24%153.43M | -64.04%4.57M | ---- | -5.20%232.95M | -49.90%77.79M | -45.66%12.71M | 76.59%2.2M | 115.35%245.73M | 215.44%155.27M | 162.65%23.4M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -38.25%706.26K | -88.37%123.94K | -96.80%30.05K | -25.82%1.39M | -38.98%1.14M | -43.07%1.07M | --939.36K | 662.16%1.87M | 5,135.28%1.87M | --1.87M |
| Cash received relating to other investing activities | 30,298.72%65.37M | --40.36M | ---- | 5.86%97M | -99.22%215.04K | ---- | ---- | -61.11%91.63M | -74.74%27.5M | -98.99%1.07M |
| Cash inflows from investing activities | 177.33%219.51M | 227.03%45.06M | -99.04%30.05K | -10.35%331.33M | -61.55%79.15M | -47.69%13.78M | 152.12%3.14M | -49.94%369.58M | -62.32%205.86M | -94.76%26.34M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 132.85%1.87B | 219.71%1.49B | 243.04%668.07M | -64.44%1.48B | -66.85%804.73M | -72.37%465.34M | -68.98%194.75M | 29.65%4.17B | 16.41%2.43B | 82.69%1.68B |
| Cash paid to acquire investments | 108.90%299.98M | 176.34%264.91M | -88.38%4.94M | -18.94%610.64M | -78.20%143.6M | -84.16%95.87M | -65.32%42.5M | 125.62%753.36M | 431.12%658.73M | 572.61%605.35M |
| Net cash paid to acquire subsidiaries and other business units | -99.07%837.19K | -99.02%837.19K | --0 | 473.32%584.11M | 85.78%89.73M | 76.23%85.12M | -87.62%5.98M | -95.94%101.88M | -97.99%48.3M | -97.95%48.3M |
| Cash paid relating to other investing activities | -21.15%103.98M | -44.18%68.08M | -5.44%20.84M | 60.93%237.36M | 18.96%131.86M | 47.27%121.98M | 5.96%22.03M | -31.56%147.49M | -0.45%110.85M | 34.38%82.83M |
| Cash outflows from investing activities | 94.77%2.28B | 137.09%1.82B | 161.57%693.85M | -43.64%2.91B | -63.95%1.17B | -68.26%768.3M | -67.63%265.26M | -17.55%5.17B | -31.24%3.25B | -29.43%2.42B |
| Net cash flows from investing activities | -88.78%-2.06B | -135.45%-1.78B | -164.69%-693.82M | 46.20%-2.58B | 64.11%-1.09B | 68.49%-754.52M | 67.97%-262.13M | 13.23%-4.8B | 27.17%-3.04B | 18.21%-2.39B |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | 157.66%369.42M | 4,610.70%294.42M | 4,771.11%109.6M | -94.65%180.84M | -95.69%143.37M | -99.81%6.25M | -98.73%2.25M | 657.87%3.38B | 576.30%3.33B | 828.57%3.27B |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | 157.66%369.42M | 4,610.70%294.42M | 4,771.11%109.6M | -52.59%180.84M | -56.03%143.37M | -97.70%6.25M | --2.25M | -14.50%381.41M | -33.71%326.05M | -23.00%271.21M |
| Cash from borrowing | 30.08%5.53B | 29.47%4.47B | 29.56%2.41B | 2.69%8.4B | -32.92%4.25B | -38.13%3.45B | -47.34%1.86B | -31.13%8.18B | -40.23%6.34B | -43.33%5.58B |
| Cash received relating to other financing activities | 2,144.38%1.08B | 8,831.41%223.29M | --25M | 2.05%488.66M | -78.55%48.27M | -88.42%2.5M | ---- | 0.40%478.85M | -39.44%225M | -91.61%21.59M |
| Cash inflows from financing activities | 57.17%6.98B | 44.09%4.99B | 36.65%2.54B | -24.67%9.07B | -55.08%4.44B | -60.98%3.46B | -49.99%1.86B | -5.93%12.04B | -13.76%9.89B | -15.15%8.87B |
| Borrowing repayment | 51.24%5.04B | 22.25%3.26B | 22.51%1.99B | 10.07%6.73B | -33.32%3.33B | -39.04%2.67B | -21.46%1.62B | -26.39%6.12B | -28.76%5B | -26.46%4.37B |
| Dividend interest payment | -26.17%824.45M | 0.06%506.78M | -14.93%224.75M | 4.60%1.34B | 14.18%1.12B | -4.41%506.47M | -0.10%264.2M | 11.70%1.29B | -10.63%977.95M | 8.45%529.85M |
| -Including:Cash payments for dividends or profit to minority shareholders | -28.57%31.67M | -47.31%9.97M | ---- | -38.78%103.4M | -26.13%44.34M | -61.15%18.93M | --18.93M | 123.41%168.89M | -0.18%60.02M | 345.61%48.72M |
| Cash payments relating to other financing activities | 30.50%1.12B | 43.16%619.15M | 52.43%221.09M | -20.88%1.8B | -50.78%859.17M | -71.67%432.47M | -87.25%145.04M | 7.16%2.28B | -13.25%1.75B | -14.94%1.53B |
| Cash outflows from financing activities | 31.60%6.98B | 21.64%4.39B | 19.78%2.44B | 2.06%9.88B | -31.25%5.31B | -43.94%3.61B | -41.41%2.03B | -16.46%9.68B | -23.72%7.72B | -21.87%6.43B |
| Net cash flows from financing activities | 99.74%-2.23M | 521.74%603.23M | 160.37%105.08M | -134.24%-808.44M | -139.89%-865.08M | -105.85%-143.03M | -170.41%-174.05M | 94.51%2.36B | 61.16%2.17B | 9.69%2.44B |
| Net cash flow | ||||||||||
| Net increase in cash and cash equivalents | 558.45%1.61B | -551.08%-98.56M | -408.96%-133.91M | -2,861.49%-567.27M | -71.44%244.1M | -97.68%21.85M | 86.55%-26.31M | 101.46%20.54M | 183.10%854.59M | 311.96%939.87M |
| Add:Begin period cash and cash equivalents | -23.45%1.85B | -23.45%1.85B | -23.45%1.85B | 0.86%2.42B | 0.86%2.42B | 0.86%2.42B | 0.86%2.42B | -36.99%2.4B | -36.99%2.4B | -36.99%2.4B |
| End period cash equivalent | 29.89%3.46B | -28.17%1.75B | -28.21%1.72B | -23.45%1.85B | -18.14%2.66B | -26.88%2.44B | 8.63%2.39B | 0.86%2.42B | 17.09%3.25B | -17.26%3.34B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.